ResearcherNortheastern UniversityNo recent work listed
Amit Singh
Matched on OpenAlex author ID A5103558150. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper
Papers 3
- In vitro model of inflammatory, hypoxia, and cancer stem cell signaling in pancreatic cancer using heterocellular 3-dimensional spheroids Co-author DOI 10.1101/454397↗
- EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model. Co-author DOI 10.1016/j.nano.2015.11.010↗
- Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabine in the treatment of pancreatic cancer. First author DOI 10.1186/1471-2407-14-75↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mansoor M. Amiji · 3 shared papers, 2014–2018 · strength 0.27
- Paper In vitro model of inflammatory, hypoxia, and cancer stem cell signaling in pancreatic cancer using heterocellular 3-dim… DOI 10.1101/454397↗
- Paper EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model. DOI 10.1016/j.nano.2015.11.010↗
- Paper Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabi… DOI 10.1186/1471-2407-14-75↗
- George Mattheolabakis · 2 shared papers, 2016–2018 · strength 0.20
- Paper In vitro model of inflammatory, hypoxia, and cancer stem cell signaling in pancreatic cancer using heterocellular 3-dim… DOI 10.1101/454397↗
- Paper EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model. DOI 10.1016/j.nano.2015.11.010↗
- Megha Suresh · 1 shared paper, 2018 · strength 0.12
- Jing Xu · 1 shared paper, 2014 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.